Fig. 1

Receiver operating characteristics (ROC) curves for different marker combinations to discriminate malignant from benign nodules. IL interleukin, EGF epidermal growth factor, HGF hepatocyte growth factor, MIG monokine induced by interferon gamma, Ang-1 angiopoietin-1, Gal-3 galectin-3, VDBP vitamin D binding protein